Specific induction and long-term maintenance of high purity ventricular cardiomyocytes from human induced pluripotent stem cells.

Specific induction and long-term maintenance of high purity ventricular cardiomyocytes from human induced pluripotent stem cells.

Currently, cardiomyocyte (CM) differentiation methods require a purification step after CM induction to ensure the high purity of the cell population. Here we show an improved human CM differentiation protocol with which high-purity ventricular-type CMs can be obtained and maintained without any CM...

Full description

Bibliographic Details
Main Authors:	Hiroyuki Fukushima, Miki Yoshioka, Masahide Kawatou, Víctor López-Dávila, Masafumi Takeda, Yasunari Kanda, Yuko Sekino, Yoshinori Yoshida, Jun K Yamashita
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2020-01-01
Series:	PLoS ONE
Online Access:	https://doi.org/10.1371/journal.pone.0241287

Similar Items

Overexpression of KCNJ2 in induced pluripotent stem cell-derived cardiomyocytes for the assessment of QT-prolonging drugs
by: Min Li, et al.
Published: (2017-06-01)

Development of correction formula for field potential duration of human induced pluripotent stem cell-derived cardiomyocytes sheets
by: Hiroko Izumi-Nakaseko, et al.
Published: (2017-09-01)

Proarrhythmia risk prediction using human induced pluripotent stem cell-derived cardiomyocytes
by: Daiju Yamazaki, et al.
Published: (2018-04-01)

Application of human induced pluripotent stem cell-derived cardiomyocytes sheets with microelectrode array system to estimate antiarrhythmic properties of multi-ion channel blockers
by: Hiroko Izumi-Nakaseko, et al.
Published: (2018-08-01)

International Multisite Study of Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes for Drug Proarrhythmic Potential Assessment
by: Ksenia Blinova, et al.
Published: (2018-09-01)

Efficient and scalable purification of cardiomyocytes from human embryonic and induced pluripotent stem cells by VCAM1 surface expression.
by: Hideki Uosaki, et al.
Published: (2011-01-01)

Assessment of Testing Methods for Drug-Induced Repolarization Delay and Arrhythmias in an iPS Cell–Derived Cardiomyocyte Sheet: Multi-site Validation Study
by: Yuji Nakamura, et al.
Published: (2014-01-01)

Development of torsadogenic risk assessment using human induced pluripotent stem cell-derived cardiomyocytes: Japan iPS Cardiac Safety Assessment (JiCSA) update
by: Yasunari Kanda, et al.
Published: (2018-12-01)

Modelling Torsade de Pointes arrhythmias in vitro in 3D human iPS cell-engineered heart tissue
by: Masahide Kawatou, et al.
Published: (2017-10-01)

Cardiomyocytes Derived from MHC-Homozygous Induced Pluripotent Stem Cells Exhibit Reduced Allogeneic Immunogenicity in MHC-Matched Non-human Primates
by: Takuji Kawamura, et al.
Published: (2016-03-01)

Electrophysiological Characteristics of Human iPSC-Derived Cardiomyocytes for the Assessment of Drug-Induced Proarrhythmic Potential.
by: Wataru Yamamoto, et al.
Published: (2016-01-01)

Systematic expression analysis of genes related to generation of action potentials in human iPS cell-derived cardiomyocytes
by: Masami Kodama, et al.
Published: (2019-08-01)

Optimizing the Direction and Order of the Motion Unveiled the Ability of Conventional Monolayers of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes to Show Frequency-Dependent Enhancement of Contraction and Relaxation Motion
by: Hiroko Izumi-Nakaseko, et al.
Published: (2020-09-01)

Generation of mature compact ventricular cardiomyocytes from human pluripotent stem cells
by: Shunsuke Funakoshi, et al.
Published: (2021-05-01)

Co-culture of induced pluripotent stem cells with cardiomyocytes is sufficient to promote their differentiation into cardiomyocytes.
by: Axel J Chu, et al.
Published: (2020-01-01)

Accuracy of spiked cell counting methods for designing a pre-clinical tumorigenicity study model
by: Hiroaki Osada, et al.
Published: (2020-07-01)

Modeling mutation-specific arrhythmogenic phenotypes in isogenic human iPSC-derived cardiac tissues
by: Thomas L. Maurissen, et al.
Published: (2024-01-01)

Using human induced pluripotent stem cell-derived cardiomyocytes to understand the mechanisms driving cardiomyocyte maturation
by: Homa Hamledari, et al.
Published: (2022-08-01)

Metabolic maturation of induced pluripotent stem cells derived cardiomyocytes
by: Lopez, C
Published: (2018)

In vitro effect of hydroxychloroquine on pluripotent stem cells and their cardiomyocytes derivatives
by: Michelle Vanessa Kamga Kapchoup, et al.
Published: (2023-07-01)

Expansion Culture of Human Pluripotent Stem Cells and Production of Cardiomyocytes
by: Minh Nguyen Tuyet Le, et al.
Published: (2019-05-01)

Directed Differentiation of Zebrafish Pluripotent Embryonic Cells to Functional Cardiomyocytes
by: Yao Xiao, et al.
Published: (2016-09-01)

Atomic force mechanobiology of pluripotent stem cell-derived cardiomyocytes.
by: Jianwei Liu, et al.
Published: (2012-01-01)

Modeling Catecholaminergic Polymorphic Ventricular Tachycardia using Induced Pluripotent Stem Cell-derived Cardiomyocytes
by: Atara Novak, et al.
Published: (2012-07-01)

Stage-specific regulation of signalling pathways to differentiate pluripotent stem cells to cardiomyocytes with ventricular lineage
by: Ramakanth Satthenapalli, et al.
Published: (2022-05-01)

Differentiation and characterization of rhesus monkey atrial and ventricular cardiomyocytes from induced pluripotent stem cells
by: Xiaoqian Zhang, et al.
Published: (2017-04-01)

Geminin is required for the maintenance of pluripotency.
by: Golnaz A Tabrizi, et al.
Published: (2013-01-01)

Enhancement of pacing function by HCN4 overexpression in human pluripotent stem cell-derived cardiomyocytes
by: Yukihiro Saito, et al.
Published: (2022-04-01)

Safety confirmation of induced pluripotent stem cell-derived cardiomyocyte patch transplantation for ischemic cardiomyopathy: first three case reports
by: Takuji Kawamura, et al.
Published: (2023-09-01)

Rat hair-follicle-associated pluripotent (HAP) stem cells can differentiate into atrial or ventricular cardiomyocytes in culture controlled by specific supplementation.
by: Nanako Takaoka, et al.
Published: (2024-01-01)

Rat hair-follicle-associated pluripotent (HAP) stem cells can differentiate into atrial or ventricular cardiomyocytes in culture controlled by specific supplementation
by: Nanako Takaoka, et al.
Published: (2024-01-01)

The role of NF-κB signaling in the maintenance of pluripotency of human induced pluripotent stem cells.
by: Osamu Takase, et al.
Published: (2013-01-01)

We heart cultured hearts. A comparative review of methodologies for targeted differentiation and maintenance of cardiomyocytes derived from pluripotent and multipotent stem cells
by: A. Arabadjiev, et al.
Published: (2014-12-01)

Therapy with Cardiomyocytes Derived from Pluripotent Cells in Chronic Chagasic Cardiomyopathy
by: Guilherme Visconde Brasil, et al.
Published: (2020-07-01)

Atrial cardiomyocytes development from human induced pluripotent stem cells
by: Yuan, M
Published: (2018)

Induced pluripotent stem cell derived cardiomyocytes as models for cardiac arrhythmias
by: Maaike eHoekstra, et al.
Published: (2012-08-01)

Bioengineering Approaches to Mature Human Pluripotent Stem Cell-Derived Cardiomyocytes
by: Xuetao Sun, et al.
Published: (2017-03-01)

Calcium handling in human induced pluripotent stem cell derived cardiomyocytes.
by: Ilanit Itzhaki, et al.
Published: (2011-01-01)

JAK2 as a surface marker for enrichment of human pluripotent stem cells-derived ventricular cardiomyocytes
by: Lee Chuen Liew, et al.
Published: (2023-12-01)

Exosomes From Induced Pluripotent Stem Cell–Derived Cardiomyocytes Promote Autophagy for Myocardial Repair
by: Michelle R. Santoso, et al.
Published: (2020-03-01)